Biophytis S.A.
BPTSY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$481.8K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $481,797.00 |
|---|---|
| Enterprise Value | $8.00 Million |
| Earnings per Share | $-2 |
| Beta | 0.9 |
| Outstanding Shares | 1,927,188 |
Return
| Return on Equity | 357.68% |
|---|---|
| Return on Assets | -262.08% |
| Return on Invested Capital | 377.24% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.03 |
| Price to Sales | - |
| Price to Book Ratio | -0.06 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.39 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.21 |
| Debt to Equity | -1.52 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 11, 2026
EPS Estimate
$-39.98
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
$-46.88
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Biophytis
2,020 employees
CEO: Stanislas Veillet
Biophytis S.A. is a clinical-stage biotechnology company dedicated to creating therapies designed to mitigate age-related degenerative processes and enhance functional well-being for patients. The company's scientific approach centers on...